We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+13.18%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$20.1M
Cap. Flow
+$1.08M
Cap. Flow %
0.44%
Top 10 Hldgs %
56.55%
Holding
90
New
8
Increased
18
Reduced
14
Closed
17

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.55M
2
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$1.06M
3
INTC icon
Intel
INTC
+$1.02M
4
T icon
AT&T
T
+$804K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$738K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.61M
2
BABA icon
Alibaba
BABA
+$2.15M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$1.92M
4
AMD icon
Advanced Micro Devices
AMD
+$1.34M
5
PSFE icon
Paysafe
PSFE
+$853K

Sector Composition

Rank Sector Weight
1 Healthcare 39.97%
2 Technology 13.69%
3 Communication Services 7.37%
4 Financials 4.79%
5 Consumer Discretionary 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOD
26
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.65M 1.07%
259,000
– –
VZ icon
27
Verizon
VZ
$195B
$2.6M 1.05%
50,000
-50,000
-50% -$2.61M
ALT icon
28
Altimmune
ALT
$552M
$2.57M 1.04%
280,700
+41,500
+17% +$441K
GDXJ icon
29
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$2.31M 0.94%
55,000
+15,000
+38% +$642K
T icon
30
AT&T
T
$159B
$2.28M 0.92%
122,470
+43,030
+54% +$804K
AAPL icon
31
Apple
AAPL
$4.54T
$2.22M 0.9%
12,500
– –
IMPL
32
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$2.21M 0.9%
256,027
+106,027
+71% +$1.06M
SGEN
33
DELISTED
Seagen Inc. Common Stock
SGEN
$2.09M 0.85%
13,500
– –
BMY icon
34
Bristol-Myers Squibb
BMY
$133B
$2.03M 0.82%
32,500
– –
ORCL icon
35
CALL
Oracle
ORCL
$374B
$1.96M 0.8%
+22,500
New +$2.11M
HON icon
36
CALL
Honeywell
HON
$77B
$1.88M 0.76%
+9,549
New +$1.93M
LNSR icon
37
LENSAR
LNSR
$61.5M
$1.68M 0.68%
279,788
– –
MRVL icon
38
Marvell Technology
MRVL
$168B
$1.53M 0.62%
17,500
– –
SLV icon
39
iShares Silver Trust
SLV
$28B
$1.45M 0.59%
67,500
-12,500
-16% -$270K
QCOM icon
40
Qualcomm
QCOM
$155B
$1.37M 0.56%
7,500
– –
AERI
41
DELISTED
Aerie Pharmaceuticals
AERI
$1.35M 0.55%
192,065
+55,564
+41% +$581K
MS icon
42
Morgan Stanley
MS
$331B
$1.23M 0.5%
12,500
– –
STEW
43
SRH Total Return Fund
STEW
$1.79B
$1.18M 0.48%
83,000
– –
INTC icon
44
Intel
INTC
$455B
$1.03M 0.42%
+20,000
New +$1.02M
NOK icon
45
Nokia
NOK
$51B
$933K 0.38%
150,000
– –
MU icon
46
PUT
Micron Technology
MU
$930B
$932K 0.38%
+10,000
New +$781K
ITW icon
47
Illinois Tool Works
ITW
$82.6B
$864K 0.35%
3,500
– –
MSFT icon
48
Microsoft
MSFT
$3.45T
$841K 0.34%
2,500
– –
VIR icon
49
Vir Biotechnology
VIR
$1.46B
$837K 0.34%
20,000
-8,000
-29% -$313K
NXPI icon
50
NXP Semiconductors
NXPI
$57.8B
$797K 0.32%
3,500
– –
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, DCF Advisers held 90 positions worth $247M, up 8.9% from $227M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

DCF Advisers's Q4 2021 filing shows 8 new, 18 increased, 14 reduced and 17 closed positions. Its largest new stake was Intel: 20,000 shares worth $1.03M. The largest sale was Verizon, an estimated $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q4 2021 buy was Intel: 20,000 shares worth $1.03M.
  • DCF Advisers added most to AbbVie in Q4 2021, an estimated $2.55M increase.
  • DCF Advisers's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.61M.
  • DCF Advisers fully exited Alibaba in Q4 2021, selling an estimated $2.15M.
  • DCF Advisers's ten largest holdings make up 57% of its $247M portfolio in Q4 2021.
  • DCF Advisers opened 8 new positions and closed 17 in Q4 2021.
  • DCF Advisers's portfolio value rose 8.9% quarter-over-quarter to $247M.

Based on DCF Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.